Srikanth Manupati

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Resistin–A Plausible Therapeutic Target in the Pathogenesis of Psoriasis
  Immunological Investigations 2024 DOI: 10.1080/08820139.2023.2288836
  +Save
• Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX
  Bioorganic Chemistry 2023 DOI: 10.1016/j.bioorg.2023.106606
  +Save
• 3, 3′- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice
  International Immunopharmacology 2022 DOI: 10.1016/j.intimp.2022.108795
  +Save
• 3,3'-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice.
  +Save
• IL-17A/IL-17RA interaction blockade sensitizes synovial macrophages to efferocytosis and PD-L1 signaling via rewiring STAT-3/ADAM17/MERTK axis in rheumatoid arthritis animal model
  +Save